Articles
Hey everybody, welcome to another installment of Weekly Thoughts. This week we get an encouraging update about the logistics of Shiseido’s trial and more information about the RiverTown Therapeutics Inc. compound. Shiseido Closer to Trial News was finally released this week about Shiseido’s upcoming trial in Japan using Replicel’s RCH-01 technology. Shiseido acquired an exclusive…
Read More
Hello everyone and welcome to another edition of Weekly Thoughts. We’re now past the halfway point of the year, and quite frankly, I think a lot of people expected there to be more news regarding pivotal clinical trails for some of our favorite hair growth technologies. Nonetheless, the good news continues to pour in and…
Read MoreHello Everyone, Welcome to another edition of Weekly Thoughts. This edition features a presentation update on the JAK inhibitor therapies for hair growth and the announcement of a new startup/treatment for hair growth that is also claimed to restore hair pigment. Wowzas. Let’s take a look. Aclaris Therapeutics Jeffries Presentation Acalaris Therapeutics CEO Dr. Neal…
Read More
Last summer I was happy to discover BiologicsMD, a new biotech startup coming out of Fayetteville, Arkansas. At that time, the company had just announced a new patent for the uses of bone growth, hair growth, and prevention of hair loss. You might imagine it was the latter two that caught my eye. It’s been…
Read More
A professor from Hebei University of Science and Technology, Chunyu Han, has developed a potentially groundbreaking genome editing technology. The technology is similar in nature to the CRISPR-Cas9 method but uses DNA-guided genome editing instead of RNA-guided genome editing. Han’s work was published in the May 2nd edition of the Nature Biotechnology Journal and has…
Read More
I wanted to give everyone a quick update on one of the hottest topics in the hair growth treatment world, the Brotzu lotion. Dr. Giovanni (John) Brotzu made a presentation last weekend at an Italian Alopecia Areata Association meeting. The presentation contains a few interesting new tidbits and is completely in Italian, but is somewhat…
Read MoreHello Everybody, It’s nice to be back here with you all for another installment of Weekly Thoughts. I’m personally excited about several items discussed in this edition. Let’s see what’s going on in the hair world this week. BiologicsMD New Site Layout With Pipeline BiologicsMD, a biotech startup which is affiliated with the University of…
Read MoreHey there everybody, nice to see you all again. In this edition of Weekly Thoughts we find a new company with some ambiguous, yet noteworthy, claims about their hair growth technology, an update on Follica’s new pivot, and some background information on Samumed’s founder and CEO. Thorn Medical Makes Big Claim Last week, a press…
Read MoreOriginally published April 8, 2016 This is a discussion that I have planned to do for a while now. After reading about a new hair growth treatment that was announced yesterday, and knowing I would soon be sharing it with you all, I decided it was time to write this article first. When writing these…
Read MoreWell you guys asked for it, right? An established pharmaceutical company has acquired the rights to Angela Christiano’s hair growth research involving JAK inhibitors. Aclaris Therapeutics has entered into an agreement with Vixen to acquire all of the stock of Vixen Pharmaceuticals. For those unaware, Vixen Pharma is the small startup company that Christiano founded…
Read More